Sourcebio International (LON:SBI) Shares Up 4.5% – Should You Buy?

Sourcebio International Plc (LON:SBI)’s share price was up 4.5% during mid-day trading on Tuesday . The company traded as high as GBX 125 ($1.63) and last traded at GBX 115 ($1.50). Approximately 1,571,282 shares were traded during trading, an increase of 931% from the average daily volume of 152,444 shares. The stock had previously closed at GBX 110 ($1.43).

Sourcebio International Trading Up 4.5 %

The company has a debt-to-equity ratio of 35.10, a quick ratio of 1.78 and a current ratio of 1.91. The company has a market capitalization of £85.31 million and a price-to-earnings ratio of 1,277.78. The business’s 50-day simple moving average is GBX 115 and its 200-day simple moving average is GBX 115.

About Sourcebio International

Sourcebio International Plc, together with its subsidiaries, provides various laboratory services and products to clients in the healthcare, clinical, life science research, and biopharma industries in the United Kingdom, Europe, the United States, and internationally. The company's services cover histopathology cancer screening and clinical diagnostic services; DNA sequencing services and precision medicine to pharmaceutical and biotechnology companies, academia, contract research organizations, and other research markets; shelf-life testing services and equipment; and COVID-19 antigen PCR testing services.